Did you know that about 2.3 million women are diagnosed with breast cancer each year? Breast cancer occurs when abnormal cells in the breast grow uncontrollably and end up forming a tumor. These cancer cells can invade nearby tissues. As a result, it spreads to other parts of the body through the blood or lymphatic system. This process is called metastasis.
Breast cancer usually develops in milk ducts or milk-producing lobules. The primary cause is unknown; several factors can increase the risk of breast cancer. It includes:
- Increasing age
- Family history of breast or ovarian cancer
- Inherited gene mutations such as BRCA1 and BRCA2
- Hormonal factors
- Obesity
- Alcohol consumption
- Lack of physical activity
Common symptoms of breast cancer are:
- A lump or thickened area in the breast or underarm
- Changes in the size or shape of the breast
- Skin dimpling or redness
- Nipple discharge, especially if bloody
- Pain in the breast or nipple (less common in early stages)
Researchers classify breast cancer into several subtypes, including:
- Hormone receptor-positive (HR-positive) breast cancer
- HER2-positive breast cancer
- Triple-negative breast cancer (TNBC)
Early detection through regular screening and timely diagnosis improves the chances of successful treatment. That is why researchers study different proteins that can significantly impact breast cancer development. Here is where HSP-90 ELISA kits come into play.
What is HSP-90?
Cancer cells experience constant stress because they grow rapidly and produce many abnormal proteins. To survive, they produce higher levels of Heat Shock Protein 90 (HSP-90).
HSP-90 acts as a molecular chaperone. It:
- Helps proteins fold correctly
- Stabilizes cancer-promoting proteins
- Prevents damaged proteins from breaking down
- Supports cell survival during stress
Under normal conditions, HSP-90 is present in almost every cell. However, many cancer cells produce much higher amounts of HSP-90 because they rely on it to survive and continue growing.
If HSP-90 activity is blocked, many of these cancer-promoting proteins become unstable and are destroyed.
This makes HSP-90 an attractive target for breast cancer research and drug development.
What are HSP-90 ELISA kits?
ELISA stands for Enzyme-Linked Immunosorbent Assay. It is a plate-based technique used to detect specific antibodies, proteins, hormones, etc., in a biological sample. It relies on antigen-antibody interactions. It is known for high specificity and sensitivity.
A HSP-90 ELISA kit is designed to specifically bind to the HSP-90 protein. Once the antibodies bind to HSP-90, an enzyme-linked antibody is added to the sample, which further produces a color change. The intensity of color is directly proportional to the amount of HSP-90 present in the sample. The stronger the color, the higher the level of HSP-90.
How does the HSP-90 ELISA Kit Help in Breast Cancer Research?
Study HSP-90 Expressions
Researchers compare HSP-90 levels in healthy breast tissue and cancerous tissue to understand how its expression changes during disease development. They may also compare protein levels across different stages of breast cancer.
These studies help scientists determine whether HSP-90 becomes more abundant as tumors grow or become more aggressive. These expression patterns provide valuable insights into the biology of breast cancer and help identify possible therapeutic targets.
Understand Tumor Biology
Breast cancer is driven by many proteins that control cell growth, survival, DNA repair, and communication between cells. Many of these proteins rely on HSP-90 to remain functional.
At times, researchers use a HSP-90 ELISA kit to measure changes in HSP-90 levels. This also helps them study different cellular pathways involved in breast cancer.
In addition, this allows scientists to investigate how HSP-90 contributes to:
- Rapid cell division
- Tumor growth
- Resistance to programmed cell death (apoptosis)
- Activation of cancer-related signaling pathways
- Protein stability within cancer cells
With the results, scientists can understand how breast cancer develops and progresses.
Evaluate HSP-90 Inhibitors
Since HSP-90 helps support cancer cells, researchers have developed drugs called HSP-90 inhibitors that block its activity.
Before these drugs can move into clinical studies, scientists must determine whether they effectively reduce HSP-90 activity in laboratory models.
A HSP-90 ELISA kit helps researchers measure protein levels before and after treatment with experimental drugs.
After this, scientists compare the results to evaluate:
- Whether the drug successfully affects HSP-90-related pathways
- How cancer cells respond to treatment
- Whether protein stability decreases after HSP-90 inhibition
- The effectiveness of different drug concentrations
These experiments further help develop new targeted therapies for breast cancer.
Monitor Cellular Stress
Cancer cells live under constant stress due to rapid growth, limited oxygen, nutrient shortages, and exposure to treatments such as chemotherapy or radiation.
HSP-90 helps cancer cells survive these stressful conditions by protecting damaged proteins and maintaining normal cellular functions.
So, researchers use HSP-90 ELISA kits to monitor changes in HSP-90 levels when breast cancer cells are exposed to different stress conditions, including:
- Heat stress
- Oxidative stress
- Chemotherapy drugs
- Radiation therapy
- Targeted cancer therapies
This helps scientists understand how cancer cells adapt and survive under treatment-induced stress. In addition, it helsp contribute to the development of more effective therapeutic strategies.
Compare Different Breast Cancer Types
Breast cancer is not a single disease. Different subtypes behave differently and respond to different treatments.
Researchers often compare HSP-90 expression among:
- Hormone receptor-positive breast cancer
- HER2-positive breast cancer
- Triple-negative breast cancer (TNBC)
A HSP-90 ELISA kit provides quantitative data that allows scientists to determine whether certain breast cancer subtypes produce higher levels of HSP-90 than others.
This further helps in understanding disease biology and may help explain why some breast cancers grow faster or respond differently to treatment.
The Bottom Line
Now that you know how HSP-90 ELISA helps in breast cancer research, what are you waiting for? Find a reliable supplier to buy high-quality kits that provide you with reproducible results for your experiment.
+ There are no comments
Add yours